Work

(18)F-FDG PET in sarcoma treatment response imaging.

Year: 2011

Type: article

Abstract: Sarcomas are a biologically complex group of diseases that exhibit variable responses to single or combination therapy. (18)F-FDG PET imaging contributes to sarcoma treatment response assessment as an objective semiquantitative biomarker of response. In this review, background and experience in (18)F-FDG PET as a biomarker that successfully identifies tumor response is assessed.

Source: PubMed

Authors: Janet F Eary, Douglas S Hawkins, Eve T Rodler, Ernest U Conrad

Institutions: Seattle Children's Hospital, University of Washington

Language: English

Topic: Medical Imaging Techniques and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Molecular Imaging of Cancer and Its Response to Therapy, PET in Sarcoma - A Clinical Trial